Back

Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study

2 September 2024 (13:25 - 13:35)
Organised by: Logo
Congress Presentation Part of: The interplay between atrial fibrillation and heart failure: implications for clinicians Heart Failure in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Paul M Haller

Medical University of Vienna, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
Incidence of atrial fibrillation detected by an insertable cardiac monitor in a large real-world cohort of heart failure patients with reduced and preserved ejection fraction
Mr S. Sarkar (Moundsview, US)
Abstract Slides Video
Presentation thumbnail
Long-term risk of heart failure and postoperative atrial fibrillation following noncardiac surgery: not so different from non-surgical atrial fibrillation
Ms M. Karacan (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Prognostic implication of right ventricular - pulmonary arterial coupling in patients with non-valvular atrial fibrillation
Assistant Professor D. Kim (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Prevalence and implications of cardiomyopathy-associated genetic variants in early-onset atrial fibrillation
Miss L. Wijdeveld (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Atrial Fibrillation (AF) detected by repeat handheld ECG screening and the risk of heart failure hospitalization
Doctor W. Sun (Shatin, HK)
Abstract Slides Video

Access the full session

Session thumbnail
The interplay between atrial fibrillation and heart failure: implications for clinicians
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 13:25 CET
You may be interested in
thumbnail
Congress Session
Biomarkers definning pathophysiology and prognosis
thumbnail
Congress Session
Novel diagnostic approaches in heart failure
thumbnail
Congress Presentation
Biomarkers for improved risk prediction and biological insights in patients with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources